XML 74 R56.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Balance Sheet Account Details - Contingent Liabilities (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2021 | Dec. 31, 2020
Contingent Liability [Roll Forward] |  |
Commercial rights at beginning of period | $ 49,133 | $ 8,942
Additional Contingent Liabilities |  | 41,800
Payments | (1,820) | (2,325)
Fair Value Adjustment | (36,242) | 963
Repurchases | 0 | (247)
Commercial rights at end of period | 11,071 | 49,133
Cydex |  |
Contingent Liability [Roll Forward] |  |
Commercial rights at beginning of period | 508 | 348
Additional Contingent Liabilities |  | 0
Payments | (50) | 0
Fair Value Adjustment | (108) | 160
Repurchases | 0 | 0
Commercial rights at end of period | 350 | 508
Metabasis |  |
Contingent Liability [Roll Forward] |  |
Commercial rights at beginning of period | 3,821 | 5,935
Additional Contingent Liabilities |  | 0
Payments | 0 | 0
Fair Value Adjustment | (464) | (1,867)
Repurchases | 0 | (247)
Commercial rights at end of period | 3,357 | 3,821
Crystal |  |
Contingent Liability [Roll Forward] |  |
Commercial rights at beginning of period | 800 | 2,659
Additional Contingent Liabilities |  | 0
Payments | 0 | (1,800)
Fair Value Adjustment | (800) | (59)
Repurchases | 0 | 0
Commercial rights at end of period | 0 | 800
Icagen |  |
Contingent Liability [Roll Forward] |  |
Commercial rights at beginning of period | 6,404 | 0
Additional Contingent Liabilities |  | 4,800
Payments | (1,050) | (525)
Fair Value Adjustment | 2,010 | 2,129
Repurchases | 0 | 0
Commercial rights at end of period | 7,364 | 6,404
Pfenex |  |
Contingent Liability [Roll Forward] |  |
Commercial rights at beginning of period | 37,600 | 0
Additional Contingent Liabilities |  | 37,000
Payments | 0 | 0
Fair Value Adjustment | (37,600) | 600
Repurchases | 0 | 0
Commercial rights at end of period | 0 | 37,600
xCella |  |
Contingent Liability [Roll Forward] |  |
Commercial rights at beginning of period | 0 | 0
Additional Contingent Liabilities |  | 0
Payments | (720) | 0
Fair Value Adjustment | 720 | 0
Repurchases | 0 | 0
Commercial rights at end of period | $ 0 | $ 0

X
- Definition Business Acquisition Contingent Consideration Potential Cash Payment Additions + References No definition available. + Details
Name: | lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAdditions
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business Acquisition Contingent Consideration Potential Cash Payment at End of Period + References No definition available. + Details
Name: | lgnd_BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contingent Liability [Roll Forward] + References No definition available. + Details
Name: | lgnd_ContingentLiabilityRollForward
Namespace Prefix: | lgnd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Repurchases, Contingent Liabilities + References No definition available. + Details
Name: | lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRepurchasesContingentLiabilities
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Fair Value Adjustment, Contingent Liabilities + References No definition available. + Details
Name: | lgnd_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payments to contingent value right holders + References No definition available. + Details
Name: | lgnd_PaymentsToContingentValueRightHolders
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lgnd_CydexPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisTherapeuticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lgnd_CrystalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |